Browse the evidence

Soy protein supplementation reduces exercise-induced metabolic biomarkers such as triglycerides, uric acid, and lactate, and improves antioxidant status compared to whey protein in long-term studies.

Soy protein is not just about muscle; it actively helps your body handle oxidative stress and metabolic strain from exercise. It reduces lactate, uric acid, and triglycerides more effectively than some other sources. This makes it a smart choice for overall metabolic health alongside muscle building.

Higher adherence to the Food Compass nutrient profiling system, measured by an individual's Food Compass Score (i.FCS), is associated with lower all-cause mortality, improved cardiometabolic risk factors, and lower prevalence of chronic diseases in U.S. adults.

Focus on eating foods with higher Food Compass scores, which prioritize nutrient density, healthy fats, fiber, and whole ingredients while minimizing additives and ultra-processing. This dietary pattern is linked to lower risks of heart disease, diabetes, cancer, and early death. You don't need to track every nutrient; choosing foods rated highly by this system generally leads to better health outcomes.

Triple agonist retatrutide (GLP-1/GIP/glucagon) produces superior weight loss (up to 24.2% at 12mg) compared to dual agonists and GLP-1 monotherapy, driven by synergistic activation of all three receptors.

Retatrutide, a once-weekly injection targeting three gut hormones, has shown unprecedented weight loss (up to 24%) in clinical trials for obesity. While effective, it carries a risk of gastrointestinal side effects like nausea, which are usually manageable by starting at a low dose and increasing slowly. It represents a significant advancement over older GLP-1 drugs.

Sustained intentional weight loss of >10–15 kg through dietary intervention can induce remission of type 2 diabetes (HbA1c <48 mmol/mol without medication) by reducing ectopic fat in the liver and pancreas and restoring beta cell function.

To potentially reverse type 2 diabetes, you need to lose a significant amount of weight (more than 10-15 kg) and keep it off. This isn't just about lowering blood sugar with drugs; it's about removing fat from your liver and pancreas so your body can regulate blood sugar naturally again. This is most likely to work if you have had diabetes for a short time. You should seek a structured, professionally supported dietary program rather than relying solely on medication.

Tirzepatide significantly reduces ad libitum energy intake and body weight in adults with overweight or obesity, primarily by decreasing fasting appetite, food cravings, and disinhibition rather than increasing cognitive restraint.

Tirzepatide, a once-weekly injectable medication, significantly reduces food intake and body weight in adults with overweight or obesity. It works by lowering appetite, reducing food cravings, and decreasing the tendency to overeat, rather than by increasing willpower or cognitive restraint. While gastrointestinal side effects like nausea are common, they are often mild and tend to occur more frequently after the first injection. This suggests that tirzepatide can be an effective tool for managing energy intake and promoting weight loss, particularly for those who struggle with appetite and cravings.

Objective dietary assessment methods, such as biomarkers of food intake (BFIs) and image-based assessment, are superior to subjective methods (like 24-hour recalls) for monitoring dietary intake and improving adherence in obesity management.

To get the most out of your diet plan, use objective tools to track what you eat. Instead of relying on memory, which can be inaccurate, use apps that take photos of your meals or, if available, biomarker tests (like urine or blood tests) to verify your intake. This reduces guesswork and helps you stay on track with your personalized nutrition plan.

Lifestyle interventions (caloric restriction, physical activity, behavioral changes) are critical components for obesity management, with a target of 5-10% weight loss over 6 months being an appropriate initial goal.

Start with a daily caloric deficit of 500 kcal and aim for 150-300 minutes of moderate exercise per week plus strength training twice a week. Your initial goal should be 5-10% weight loss over 6 months. Focus on building sustainable habits rather than extreme diets.

High dietary fiber intake promotes gut microbiota diversity and short-chain fatty acid generation, which decreases inflammation and supports gut barrier integrity, thereby reducing type 2 diabetes risk.

Eat more minimally processed plant foods like whole grains, vegetables, fruits, legumes, nuts, and seeds. This increases gut bacteria diversity and produces beneficial compounds (SCFAs) that reduce inflammation and protect your gut barrier, lowering your risk of type 2 diabetes. Note that individual responses vary based on your current gut bacteria.

GLP-1 receptor agonists (including semaglutide, liraglutide, dulaglutide, and tirzepatide) significantly reduce hepatic lipid content and improve liver histology (steatosis, inflammation, and fibrosis) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), primarily through weight loss and direct metabolic modulation.

If you have fatty liver disease (MASLD) and struggle with weight or blood sugar, GLP-1 medications like semaglutide or tirzepatide are highly effective treatments. They don't just help you lose weight; they directly reduce fat in the liver and can reverse inflammation and early scarring. While they are injections and may cause temporary stomach upset, the clinical data shows they significantly improve liver health outcomes compared to placebo.

Long-duration static stretching (1 hour daily for 6 weeks) induces significant increases in maximal strength, muscle thickness, and range of motion in the plantar flexors for both males and females, with males demonstrating superior magnitude of adaptation.

If you want to increase calf strength and size without heavy weights, you can try static stretching for 1 hour daily using a device that holds your ankle at a stretched position. You need to feel significant discomfort (7-8/10) at the start, but it will subside. Do this for 6 weeks. Note that men will likely see bigger gains than women, but both sexes will improve strength, size, and flexibility.

GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) produce significant weight loss (6–30%+ TBWL) and improve fertility outcomes (spontaneous conception, IVF pregnancy rates) in women with obesity and PCOS when used in the preconception period.

If you have obesity and are trying to conceive, GLP-1 medications (like Wegovy or Zepbound) are highly effective for weight loss and improving fertility, especially if you have PCOS. You must stop taking them 2 months before you try to conceive to ensure the drug is out of your system. Work with your doctor to manage side effects and costs.

Supervised resistance training produces a small but statistically significant improvement in performance and functional outcomes compared to unsupervised training, with a moderate effect specifically for strength gains.

If you are training alone, expect slightly slower strength gains compared to having a coach. Supervision helps you lift heavier loads with better technique and closer to failure, which drives adaptation. If you cannot afford a coach, use video self-analysis or training logs to mimic the feedback loop of supervision.

Replacing saturated fats with monounsaturated fats from local regional sources (canola oil, pecans, avocado, moringa oil) significantly improves lipid profiles (reduces LDL/total cholesterol) and cardiovascular risk factors.

To improve your cholesterol without changing your culture, swap your current cooking fat for local monounsaturated options. In North America, use canola oil and eat pecans (approx. 42g/day). In Latin America, use avocado as your primary fat source. In Africa, consider moringa oil. These swaps have been shown in meta-analyses to lower LDL cholesterol effectively.

Incorporating high-fiber, low-glycemic index local staples (pinto beans, okra, quinoa, plantains, barley) improves glucose metabolism, insulin sensitivity, and reduces cardiovascular risk markers.

Replace refined grains and high-GI starchy foods with local high-fiber alternatives. In North America, eat pinto beans and okra. In Latin America, choose quinoa and green plantains. In Asia, choose barley. These foods provide fiber that improves insulin sensitivity and lowers cholesterol.

Slow Typology (ST) individuals must perform a significantly higher training volume to achieve the same hypertrophic and strength adaptations as Fast Typology (FT) individuals when training to failure.

If you find yourself needing to do more sets or reps than others to see muscle growth, this is normal for your muscle type. Do not compare your volume to others. Focus on completing your sets to failure, and you will achieve similar strength and muscle gains.

Increasing training frequency from 2x/week to 3x/week increases muscle hypertrophy but not maximal dynamic strength, regardless of muscle typology.

If your goal is to build muscle, training 3 times a week is likely more effective than 2 times a week, even if you only add one extra session. This benefit applies to everyone, regardless of their muscle fiber type. However, this extra frequency may not translate to greater strength gains, so prioritize hypertrophy if that is your goal.

High-volume resistance training (lighter loads, higher reps) produces greater skeletal muscle hypertrophy than high-load resistance training (heavier loads, fewer reps) when volume is equated or higher in the high-volume condition.

To maximize muscle growth, prioritize higher volume with lighter loads (around 60% of your one-rep max) performed for more repetitions (e.g., 10 reps per set) rather than just heavy loads. This approach was shown to significantly increase muscle size in trained individuals over 6 weeks, whereas heavy loads alone did not produce significant growth in this specific protocol.

High-load resistance training produces greater strength gains than high-volume resistance training, despite potentially lower hypertrophic outcomes in the short term.

If your primary goal is to increase strength, prioritize high-load training (heavier weights, fewer reps) over high-volume training. This approach was shown to produce greater strength gains in trained individuals over 6 weeks.

Regular aerobic and resistance exercise training significantly improves cardiorespiratory fitness (VO2peak) in adults with type 2 diabetes, with greater relative improvements observed in those with lower baseline fitness.

If you have type 2 diabetes and feel too tired or uncomfortable to exercise, start with 'conditioning' rather than intense workouts. Focus on gentle stretching, warm-ups, and cool-downs. Supervised aerobic exercise (60 mins, 3x/week at 70-85% max heart rate) has been shown to significantly improve your fitness (VO2peak) even more than in non-diabetic peers. Use wearable trackers or continuous glucose monitors for real-time feedback to boost motivation and self-efficacy.

The use of Continuous Glucose Monitors (CGMs) as a real-time feedback tool increases self-efficacy, exercise attendance, and total exercise time in adults with type 2 diabetes, even in those not on intensive insulin therapy.

If you have type 2 diabetes, using a Continuous Glucose Monitor (CGM) during exercise can help you see how your body responds in real-time. This feedback can boost your confidence (self-efficacy) and motivate you to exercise more, even if you aren't on insulin. Look for programs that cover CGMs for behavior change, as they can lead to increased exercise time and better metabolic control.

Wearable activity trackers (e.g., Fitbit) significantly increase daily step count and walking minutes in adults with type 2 diabetes compared to non-tracker interventions.

Wearing a simple activity tracker like a Fitbit can help you walk more. Studies show it adds an average of 627 steps per day. Set simple step goals and use the real-time feedback to stay motivated. Social accountability, such as sharing progress with a coach or group, can further enhance adherence.

Optimizing resistance training in hypoxia with moderate loads (60-80% 1RM) and short inter-set rest intervals (≤ 60s) enhances muscle hypertrophy (CSA) compared to normoxia.

If you train in hypoxia, use moderate weights (60-80% 1RM) and keep rest periods short (under 60 seconds) to potentially maximize muscle growth. Without these specific settings, hypoxia offers no advantage over normal air.

Significant weight loss (induced by metabolic surgery, very-low-calorie diets, or intensive insulin therapy) prior to irreversible beta-cell damage can induce durable remission of type 2 diabetes, defined as HbA1c <6.5% without medication.

If you have recently been diagnosed with Type 2 Diabetes, especially if overweight, aggressive intervention is critical. This may involve significant weight loss through very-low-calorie diets, metabolic surgery, or short-term intensive insulin therapy. The goal is to restore beta-cell function before damage becomes irreversible, potentially allowing you to stop medication and maintain normal blood sugar levels.

Once-daily oral semaglutide (3–14 mg) significantly reduces HbA1c (mean -1.16%-points) and body weight (mean -5.84 kg) in adults with type 2 diabetes over 34–44 weeks, with 47.5% achieving HbA1c < 7.0% and 35.5% achieving composite targets (HbA1c reduction ≥ 1.0%-points plus body weight reduction ≥ 5%).

If you have Type 2 Diabetes and are struggling with blood sugar and weight, oral semaglutide is a proven, once-daily option that can significantly lower your HbA1c and help you lose weight. Most people find it easy to take, and while stomach issues can happen, they are usually mild. It is particularly useful if you want to avoid injections.